共 50 条
- [45] Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT-1 to-4 trials DIABETES OBESITY & METABOLISM, 2025, 27 (04): : 1826 - 1835
- [46] Motivation for weight loss and association with outcomes in a lifestyle intervention: comparing emerging adults to middle aged adults OBESITY SCIENCE & PRACTICE, 2019, 5 (01): : 15 - 20